Top

Published in:

Open Access 01-12-2016 | Review

Chinese medicines in the treatment of experimental diabetic nephropathy

Authors: Jing-Yi Liu, Xiao-Xin Chen, Sydney Chi-Wai Tang, Stephen Cho-Wing Sze, Yi-Bin Feng, Kai-Fai Lee, Kalin Yan-Bo Zhang

Published in: Chinese Medicine | Issue 1/2016

Abstract

Diabetic nephropathy (DN) is a severe micro vascular complication accompanying diabetes mellitus that affects millions of people worldwide. End-stage renal disease occurs in nearly half of all DN patients, resulting in large medical costs and lost productivity. The course of DN progression is complicated, and effective and safe therapeutic strategies are desired. While the complex nature of DN renders medicines with a single therapeutic target less efficacious, Chinese medicine, with its holistic view targeting the whole system of the patient, has exhibited efficacy for DN management. This review aims to describe the experimental evidence for Chinese medicines in DN management, with an emphasis on the underlying mechanisms, and to discuss the combined use of herbs and drugs in DN treatment.

Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28:164–76.PubMedCrossRef

Liu JY, Chen XX, Tang SCW, Lao LX, Sze SCW, Lee KF, Zhang KYB. Edible plants from traditional Chinese medicine is a promising alternative for the management of diabetic nephropathy. J Funct Foods. 2015;14:12–22.CrossRef

Tripathi YB, Yadav D. Diabetic nephropathy: causes and managements. Recent Pat Endocr Metab Immune Drug Discov. 2013;7:57–64.PubMedCrossRef

Forbes JM, Fukami K, Cooper ME. Diabetic nephropathy: where hemodynamics meets metabolism. Exp Clin Endocr Diab. 2007;115:69–84.CrossRef

Somania R, Singhai AK, Shivgunde P, Jain D. Asparagus racemosus Willd (Liliaceae) ameliorates early diabetic nephropathy in STZ induced diabetic rats. Indian J Exp Biol. 2012;50:469–75.PubMed

Zelmanovitz T, Gerchman F, Balthazar AP, Thomazelli FC, Matos JD, Canani LH. Diabetic nephropathy. Diabetol Metab Syndr. 2009;1:10.PubMedCentralPubMedCrossRef

Shafiee G, Khamseh ME, Rezaei N, Aghili R, Malek M. Alteration of pulmonary function in diabetic nephropathy. J Diabetes Metab Disord. 2013;12:15.PubMedCentralPubMedCrossRef

Tachibana H, Ogawa D, Matsushita Y, Bruemmer D, Wada J, Teshigawara S, Eguchi J, Sato-Horiguchi C, Uchida HA, Shikata K, Makino H. Activation of liver X receptor inhibits osteopontin and ameliorates diabetic nephropathy. J Am Soc Nephrol. 2012;23:1835–46.PubMedCentralPubMedCrossRef

Foley RN, Culleton BF, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Cardiac disease in diabetic end-stage renal disease. Diabetologia. 1997;40:1307–12.PubMedCrossRef

10.

Gilbert RE, Connelly K, Kelly DJ, Pollock CA, Krum H. Heart failure and nephropathy: catastrophic and interrelated complications of diabetes. Clin J Am Soc Nephrol. 2006;1:193–208.PubMedCrossRef

11.

Kataya HH, Hamza AA, Ramadan GA, Khasawneh MA. Effect of licorice extract on the complications of diabetes nephropathy in rats. Drug Cheml Toxicol. 2011;34:101–8.CrossRef

12.

Sadiq S, Nagi AH, Shahzad M, Zia A. The reno-protective effect of aqueous extract of Carum carvi (black zeera) seeds in streptozotocin induced diabetic nephropathy in rodents. Saudi J Kidney Dis Transpl. 2010;21:1058–65.PubMed

13.

Mariee AD, Abd-Allah GM, El-Yamany MF. Renal oxidative stress and nitric oxide production in streptozotocin-induced diabetic nephropathy in rats: the possible modulatory effects of garlic (Allium sativum L.). Biotechnol Appl Biochem. 2009;52:227–32.PubMedCrossRef

14.

Yang M, Xu ZP, Xu CJ, Meng J, Ding GQ, Zhang XM, Weng Y. Renal protective activity of Hsian-tsao extracts in diabetic rats. Biomed Environ Sci. 2008;21:222–7.PubMedCrossRef

15.

Orsolic N, Sirovina D, Koncic MZ, Lackovic G, Gregorovic G. Effect of Croatian propolis on diabetic nephropathy and liver toxicity in mice. BMC Complement Altern Med. 2012;12:117.PubMedCentralPubMedCrossRef

16.

Yan SJ, Wang L, Li Z, Zhu DN, Guo SC, Xin WF, Yang YF, Cong X, Ma T, Shen PP, Sheng J, Zhang WS. Inhibition of advanced glycation end product formation by Pu-erh tea ameliorates progression of experimental diabetic nephropathy. J Agr Food Chem. 2012;60:4102–10.CrossRef

17.

Zheng N, Lin X, Wen Q, Kintoko, Zhang S, Xu X, Huang J, Huang R. Effect of 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from Averrhoa carambola L. (Oxalidaceae) roots, on advanced glycation end-product-mediated renal injury in type 2 diabetic KKAy mice. Toxicol Lett. 2013;219:77–84.PubMedCrossRef

18.

Kang KS, Yamabe N, Kim HY, Park JH, Yokozawa T. Effects of heat-processed ginseng and its active component ginsenoside 20(S)-Rg3 on the progression of renal damage and dysfunction in type 2 diabetic Otsuka Long-Evans Tokushima Fatty rats. Biol Pharm Bull. 2010;33:1077–81.PubMedCrossRef

19.

Liu H, Xu H, Shen C, Wu C. Effect of the best compatibility of components in Corni Fructus on WT1 expression in glomerular podocytes of type 2 diabetic rats with early nephropathy. Am J Chin Med. 2012;40:537–49.PubMedCrossRef

20.

Tang D, He B, Zheng ZG, Wang RS, Gu F, Duan TT, Cheng HQ, Zhu Q. Inhibitory effects of two major isoflavonoids in Radix Astragali on high glucose-induced mesangial cells proliferation and AGEs-induced endothelial cells apoptosis. Planta Med. 2011;77:729–32.PubMedCrossRef

21.

Zhang M, Liu M, Xiong M, Gong J, Tan X. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy. J Ethnopharmacol. 2012;141:111–8.PubMedCrossRef

22.

Yu DQ, Gao Y, Liu XH. Effects of Rhein on the hypertrophy of renal proximal tubular epithelial cells induced by high glucose and angiotensin II in rats. Zhong Yao Cai. 2010;33:570–4.PubMed

23.

Xie Y, Wang Q, Liu J, Xie J, Xue K, Tang Q. Dracorhodin perchlorate inhibit high glucose induce serum and glucocorticoid induced protein kinase 1 and fibronectin expression in human mesangial cells. Zhongguo Zhong Yao Za Zhi. 2010;35:1996–2000.PubMed

24.

Ma J, Phillips L, Wang Y, Dai T, LaPage J, Natarajan R, Adler SG. Curcumin activates the p38MPAK-HSP25 pathway in vitro but fails to attenuate diabetic nephropathy in DBA2 J mice despite urinary clearance documented by HPLC. BMC Complement Altern Med. 2010;10:67.PubMedCentralPubMed

25.

Li C, Cai F, Yang Y, Zhao X, Wang C, Li J, Jia Y, Tang J, Liu Q. Tetrahydroxystilbene glucoside ameliorates diabetic nephropathy in rats: involvement of SIRT1 and TGF-beta1 pathway. Eur J Pharmacol. 2010;649:382–9.PubMedCrossRef

26.

Lee MJ, Rao YK, Chen K, Lee YC, Chung YS, Tzeng YM. Andrographolide and 14-deoxy-11,12-didehydroandrographolide from Andrographis paniculata attenuate high glucose-induced fibrosis and apoptosis in murine renal mesangeal cell lines. J Ethnopharmacol. 2010;132:497–505.PubMedCrossRef

27.

Li X, Xiao Y, Gao H, Li B, Xu L, Cheng M, Jiang B, Ma Y. Grape seed proanthocyanidins ameliorate diabetic nephropathy via modulation of levels of AGE, RAGE and CTGF. Nephron Exp Nephrol. 2009;111:e31–41.PubMedCrossRef

28.

Omara EA, Nada SA, Farrag AR, Sharaf WM, El-Toumy SA. Therapeutic effect of Acacia nilotica pods extract on streptozotocin induced diabetic nephropathy in rat. Phytomedicine. 2012;19:1059–67.PubMedCrossRef

29.

Sefi M, Fetoui H, Soudani N, Chtourou Y, Makni M, Zeghal N. Artemisia campestris leaf extract alleviates early diabetic nephropathy in rats by inhibiting protein oxidation and nitric oxide end products. Pathol Res Pract. 2012;208:157–62.PubMedCrossRef

30.

Wang K, Wu YG, Su J, Zhang JJ, Zhang P, Qi XM. Total glucosides of paeony regulates JAK2/STAT3 activation and macrophage proliferation in diabetic rat kidneys. Am J Chinese Med. 2012;40:521–36.CrossRef

31.

Wang BL, Hu JP, Tan W, Sheng L, Chen H, Li Y. Simultaneous quantification of four active schisandra lignans from a traditional Chinese medicine Schisandra chinensis (Wuweizi) in rat plasma using liquid chromatography/mass spectrometry. J Chromatogr B. 2008;865:114–20.CrossRef

32.

Oliboni LS, Dani C, Funchal C, Henriques JA, Salvador M. Hepatoprotective, cardioprotective, and renal-protective effects of organic and conventional grapevine leaf extracts on Wistar rat tissues. Anais da Academia Brasileira de Ciencias. 2011;83:1403–11.PubMedCrossRef

33.

Zhang Q, Xiao X, Li M, Li W, Yu M, Zhang H, Sun X, Mao L, Xiang H. Attenuating effect of Fufang Xueshuantong Capsule on kidney function in diabetic nephropathy model. J Nat Med. 2013;67:86–97.PubMedCrossRef

34.

Wen X, Zeng Y, Liu L, Zhang H, Xu W, Li N, Jia X. Zhenqing recipe alleviates diabetic nephropathy in experimental type 2 diabetic rats through suppression of SREBP-1c. J Ethnopharmacol. 2012;142:144–50.PubMedCrossRef

35.

Ke HL, Zhang YW, Zhou BF, Zhen RT. Effects of Danggui Buxue Tang, a traditional Chinese herbal decoction, on high glucose-induced proliferation and expression of extracellular matrix proteins in glomerular mesangial cells. Nat Prod Res. 2012;26:1022–6.PubMedCrossRef

36.

Yiu WH, Wong DW, Chan LY, Leung JC, Chan KW, Lan HY, Lai KN, Tang SC. Tissue kallikrein mediates pro-inflammatory pathways and activation of protease-activated receptor-4 in proximal tubular epithelial cells. PLoS ONE. 2014;9:e88894.PubMedCentralPubMedCrossRef

37.

Lin M, Yiu WH, Wu HJ, Chan LY, Leung JC, Au WS, Chan KW, Lai KN, Tang SC. Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J Am Soc Nephrol. 2012;23:86–102.PubMedCentralPubMedCrossRef

38.

Singh DK, Winocour P, Farrington K. Oxidative stress in early diabetic nephropathy: fueling the fire. Nat Rev Endocrinol. 2011;7:176–84.PubMedCrossRef

39.

Chung SSM, Ho ECM, Lam KSL, Chung SK. Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol. 2003;14:S233–6.PubMedCrossRef

40.

Wada J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci. 2013;124:139–52.PubMedCrossRef

41.

Fioretto P, Barzon I, Mauer M. Is diabetic nephropathy reversible? Diabetes Res Clin Pr. 2014;104:323–8.CrossRef

42.

Gao Y, Zhang RR, Li JH, Ren M, Ren ZX, Shi JH, Pan QZ, Ren SP. Radix Astragali lowers kidney oxidative stress in diabetic rats treated with insulin. Endocrine. 2012;42:592–8.PubMedCrossRef

43.

Zhou Y, Liao Q, Luo Y, Qing Z, Zhang Q, He G. Renal protective effect of Rosa laevigata Michx by the inhibition of oxidative stress in streptozotocin-induced diabetic rats. Mol Med Rep. 2012;5:1548–54.PubMed

44.

Perez Gutierrez RM, Flores Cotera LB, Gonzalez AM. Evaluation of the antioxidant and anti-glication effects of the hexane extract from Piper auritum leaves in vitro and beneficial activity on oxidative stress and advanced glycation end-product-mediated renal injury in streptozotocin-treated diabetic rats. Molecules. 2012;17:11897–919.PubMedCrossRef

45.

Yaqoob M, Patrick AW, McClelland P, Stevenson A, Mason H, White MC, Bell GM. Relationship between markers of endothelial dysfunction, oxidant injury and tubular damage in patients with insulin-dependent diabetes mellitus. Clin Sci. 1993;85:557–62.PubMedCrossRef

46.

Zhou L, An XF, Teng SC, Liu JS, Shang WB, Zhang AH, Yuan YG, Yu JY. Pretreatment with the total flavone glycosides of Flos Abelmoschus manihot and hyperoside prevents glomerular podocyte apoptosis in streptozotocin-induced diabetic nephropathy. J Med Food. 2012;15:461–8.PubMedCentralPubMedCrossRef

47.

Wang K, Wu YG, Su J, Zhang JJ, Zhang P, Qi XM. Total glucosides of paeony regulates JAK2/STAT3 activation and macrophage proliferation in diabetic rat kidneys. Am J Chin Med. 2012;40:521–36.PubMedCrossRef

48.

Ruggenenti P, Perna A, Remuzzi G, Gruppo Italiano di Studi Epidemiologici in N. ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. ramipril efficacy in nephropathy. J Am Soc Nephrol. 2001;12:2832–7.PubMed

49.

Mann JF, Green D, Jamerson K, Ruilope LM, Kuranoff SJ, Littke T, Viberti G, Group AS. Avosentan for overt diabetic nephropathy. J Am Soc Nephrol. 2010;21:527–35.PubMedCentralPubMedCrossRef

50.

Zheng N, Lin X, Wen QW, Kintoko, Zhang SJ, Huang JC, Xu XH, Huang RB. Effect of 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from Averrhoa carambola L. (Oxalidaceae) roots, on advanced glycation end-product-mediated renal injury in type 2 diabetic KKAy mice. Toxicol Lett. 2013;219:77–84.PubMedCrossRef

51.

Lee SH, Kim YS, Lee SJ, Lee BC. The protective effect of Salvia miltiorrhiza in an animal model of early experimentally induced diabetic nephropathy. J Ethnopharmacol. 2011;137:1409–14.PubMedCrossRef

52.

Lee HS, Ku SK. Effect of Picrorrhiza Rhizoma extracts on early diabetic nephropathy in streptozotocin-induced diabetic rats. J Med Food. 2008;11:294–301.PubMedCrossRef

53.

Zhu B, Wang H. Basic theories of traditional Chinese medicine. Singing Dragon. 2011; p. 21–35.

54.

Cusumano AM, Bodkin NL, Hansen BC, Iotti R, Owens J, Klotman PE, Kopp JB. Glomerular hypertrophy is associated with hyperinsulinemia and precedes overt diabetes in aging rhesus monkeys. Am J Kidney Dis. 2002;40:1075–85.PubMedCrossRef

55.

Ohtomo S. The development of novel therapeutic targets for diabetic nephropathy: hyperinsulinemia, HIF-1, and megsin. Jpn J Vet Res. 2010;58:41.

56.

Ji W, Gong BQ. Hypolipidemic activity and mechanism of purified herbal extract of Salvia miltiorrhiza in hyperlipidemic rats. J Ethnopharmacol. 2008;119:291–8.PubMedCrossRef

57.

He H, Yang X, Zeng X, Shi M, Yang J, Wu L, Li L. Protective effect of Liuwei Dihuang decoction on early diabetic nephropathy induced by streptozotocin via modulating ET-ROS axis and matrix metalloproteinase activity in rats. J Pharm Pharmacol. 2007;59:1297–305.PubMedCrossRef

58.

Okamoto T, Park CH, Noh JS, Toriizuka K, Sei Y, Park JC, Yokozawa T. Hepato-/reno-protective activity of Chinese prescription Kangen-karyu through inhibition of AGE formation and fibrosis-related protein expression in type 2 diabetes. J Pharm Pharmacol. 2011;63:952–9.PubMedCrossRef

59.

Yokozawa T, Yamabe N, Cho EJ, Nakagawa T, Oowada S. A study on the effects to diabetic nephropathy of Hachimi-jio-gan in rats. Nephron Exp Nephrol. 2004;97:e38–48.PubMedCrossRef

60.

Nakagawa T, Yokozawa T, Yamabe N, Rhyn DY, Goto H, Shimada Y, Shibahara N. Long-term treatment with Hachimi-jio-gan attenuates kidney damage in spontaneously diabetic WBN/Kob rats. J Pharm Pharmacol. 2005;57:1205–12.PubMedCrossRef

61.

Yamabe N, Yokozawa T. Activity of the Chinese prescription Hachimi-jio-gan against renal damage in the Otsuka Long-Evans Tokushima fatty rat: a model of human type 2 diabetes mellitus. J Pharm Pharmacol. 2006;58:535–45.PubMedCrossRef

62.

Yamabe N, Kang KS, Goto E, Tanaka T, Yokozawa T. Beneficial effect of Corni Fructus, a constituent of Hachimi-jio-gan, on advanced glycation end-product-mediated renal injury in streptozotocin-treated diabetic rats. Biol Pharm Bull. 2007;30:520–6.PubMedCrossRef

63.

Yamabe N, Yokozawa T. Protective effect of Hachimi-jio-gan against the development of pancreatic fibrosis and oxidative damage in Otsuka Long-Evans Tokushima Fatty rats. J Ethnopharmacol. 2007;113:91–9.PubMedCrossRef

64.

Yokozawa T, Yamabe N, Kim HY, Kang KS, Hur JM, Park CH, Tanaka T. Protective effects of morroniside isolated from Corni Fructus against renal damage in streptozotocin-induced diabetic rats. Biol Pharm Bull. 2008;31:1422–8.PubMedCrossRef

65.

Chen G, Luo YC, Li BP, Li B, Guo Y, Li Y, Su W, Xiao ZL. Effect of polysaccharide from Auricularia auricula on blood lipid metabolism and lipoprotein lipase activity of ICR mice fed a cholesterol-enriched diet. J Food Sci. 2008;73:H103–8.PubMedCrossRef

66.

Yuan Z, He P, Cui J, Takeuchi H. Hypoglycemic effect of water-soluble polysaccharide from Auricularia auricula-judae Quel. on genetically diabetic KK-Ay mice. Biosci Biotech. Biochem. 1998;62:1898–903.

67.

Xueyu Z, Youdi L, Fei H, Lili C, Mingde L. Pharmacological actions of hyphae body of Auricularia auricula (L. ex Hook) underw and its alcoholic extract. Zhongguo Zhong Yao Za Zhi. 1994;19:430–2.

68.

Zhang Y, Xie D, Chen Y, Zhang H, Xia Z. Protective effect of Gui Qi mixture on the progression of diabetic nephropathy in rats. Exp Clin Endocrinol Diabetes. 2006;114:563–8.PubMedCrossRef

69.

Zhang YW, Xie D, Xia B, Zhen RT, Liu IM, Cheng JT. Suppression of transforming growth factor-beta1 gene expression by Danggui buxue tang, a traditional Chinese herbal preparation, in retarding the progress of renal damage in streptozotocin-induced diabetic rats. Horm Metab Res. 2006;38:82–8.PubMedCrossRef

70.

Li JP, He XL, Li Q. Clinical study on treatment of early diabetic nephropathy by tangshenling combined with telmisartan. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2006;26:415–8.PubMed

71.

He XL, Li JP, Chen YP, Zhang ZG, Lin WQ, Chen JH. Effects of Tangshenling mixture and benazepril on rats with diabetic nephropathy and its mechanism. Zhong Xi Yi Jie He Xue Bao. 2006;4:43–7.PubMedCrossRef

72.

Cai Y, Chen J, Jiang J, Cao W, He L. Zhen-wu-tang, a blended traditional Chinese herbal medicine, ameliorates proteinuria and renal damage of streptozotocin-induced diabetic nephropathy in rats. J Ethnopharmacol. 2010;131:88–94.PubMedCrossRef

73.

Wu XN. Current concept of spleen-stomach theory and spleen deficiency syndrome in TCM. World J Gastroentero. 1998;4:2–6.CrossRef

74.

Liu YZ, Song YF, Lao SX, Deng TT, Wang JH. Ultramicrostructure research of gastric mucosa of gastric abscess patients and realization of the TCM theory of “spleen-mitochondria correlation” Zhong Hua Zhong Yi Yao Za Zhi. 2007;12:2439–2442.

75.

Covington MB. Traditional Chinese medicine in the treatment of diabetes. Diabetes Spectrum. 2011;14:154–9.CrossRef

76.

Jaiswal N, Bhatia V, Srivastava SP, Srivastava AK, Tamrakar AK. Antidiabetic effect of Eclipta alba associated with the inhibition of alpha-glucosidase and aldose reductase. Nat Prod Res. 2012;26:2363–7.PubMedCrossRef

77.

Ramkumar KM, Ponmanickam P, Velayuthaprabhu S, Archunan G, Rajaguru P. Protective effect of Gymnema montanum against renal damage in experimental diabetic rats. Food Chem Toxicol. 2009;47:2516–21.PubMedCrossRef

78.

Shen Y, Fukushima M, Ito Y, Muraki E, Hosono T, Seki T, Ariga T. Verification of the antidiabetic effects of cinnamon (Cinnamomum zeylanicum) using insulin-uncontrolled type 1 diabetic rats and cultured adipocytes. Biosci Biotech Bioch. 2010;74:2418–25.CrossRef

79.

Tu Q, Qin J, Dong H, Lu F, Guan W. Effects of Panax notoginoside on the expression of TGF-beta1 and Smad-7 in renal tissues of diabetic rats. J Huazhong U Sci-Med. 2011;31:190–3.CrossRef

80.

Honore SM, Cabrera WM, Genta SB, Sanchez SS. Protective effect of yacon leaves decoction against early nephropathy in experimental diabetic rats. Food Chem Toxicol. 2012;50:1704–15.PubMedCrossRef

81.

Vessal G, Akmali M, Najafi P, Moein MR, Sagheb MM. Silymarin and milk thistle extract may prevent the progression of diabetic nephropathy in streptozotocin-induced diabetic rats. Ren Fail. 2010;32:733–9.PubMedCrossRef

82.

Chiu J, Khan ZA, Farhangkhoee H, Chakrabarti S. Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappa B. Nutrition. 2009;25:964–72.PubMedCrossRef

83.

Kuang QT, Zhao JJ, Ye CL, Wang JR, Ye KH, Zhang XQ, Wang Y, Ye WC. Nephro-protective effects of total triterpenoids from Psidium guajava leaves on type 2 diabetic rats. Zhong Yao Cai. 2012;35:94–7.PubMed

84.

Tu QN, Dong H, Lu FE. Effects of Panax notoginoside on the nephropathy in rats with type 1 diabetes mellitus. Chin J Integr Med. 2011;17:612–5.PubMedCrossRef

85.

Xue W, Lei J, Li X, Zhang R. Trigonella foenum graecum seed extract protects kidney function and morphology in diabetic rats via its antioxidant activity. Nutr Res. 2011;31:555–62.PubMedCrossRef

86.

Qi MY, Kai C, Liu HR, Su YH, Yu SQ. Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor beta1 and type IV collagen expression in rats. J Ethnopharmacol. 2011;138:731–6.PubMedCrossRef

87.

Liu IM, Tzeng TF, Liou SS, Chang CJ. Angelica acutiloba root alleviates advanced glycation end-product-mediated renal injury in streptozotocin-diabetic rats. J Food Sci. 2011;76:H165–74.PubMedCrossRef

88.

Zhang H, Sun W, Wan Y, Che X, He F, Pu H, Dou C. Preventive effects of multi-glycoside of Tripterygium wilfordii on glomerular lesions in experimental diabetic nephropathy. Zhongguo Zhong Yao Za Zhi. 2010;35:1460–5.PubMed

89.

Lee WC, Wang CJ, Chen YH, Hsu JD, Cheng SY, Chen HC, Lee HJ. Polyphenol extracts from Hibiscus sabdariffa Linnaeus attenuate nephropathy in experimental type 1 diabetes. J Agr Food Chem. 2009;57:2206–10.CrossRef

90.

Sen S, Chen S, Feng B, Wu Y, Lui E, Chakrabarti S. Preventive effects of North American ginseng (Panax quinquefolium) on diabetic nephropathy. Phytomedicine. 2012;19:494–505.PubMedCrossRef

91.

Gao Q, Qin WS, Jia ZH, Zheng JM, Zeng CH, Li LS, Liu ZH. Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy. Planta Med. 2010;76:27–33.PubMedCrossRef

92.

Lee AS, Lee YJ, Lee SM, Yoon JJ, Kim JS, Kang DG, Lee HS. An aqueous extract of Portulaca oleracea ameliorates diabetic nephropathy through suppression of renal fibrosis and inflammation in diabetic db/db mice. Am J Chinese Med. 2012;40:495–510.CrossRef

93.

Elmarakby AA, Ibrahim AS, Faulkner J, Mozaffari MS, Liou GI, Abdelsayed R. Tyrosine kinase inhibitor, genistein, reduces renal inflammation and injury in streptozotocin-induced diabetic mice. Vasc Pharmacol. 2011;55:149–56.CrossRef

94.

Li GS, Jiang WL, Yue XD, Qu GW, Tian JW, Wu J, Fu FH. Effect of astilbin on experimental diabetic nephropathy in vivo and in vitro. Planta Med. 2009;75:1470–5.PubMedCrossRef

95.

Lin CY, Yin MC. Renal protective effects of extracts from guava fruit (Psidium guajava L.) in diabetic mice. Plant Foods Hum Nutr. 2012;67:303–8.PubMedCrossRef

96.

Chao CY, Mong MC, Chan KC, Yin MC. Anti-glycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice. Mol Nutr Food Res. 2010;54:388–95.PubMedCrossRef

97.

Sayed AA, Khalifa M. Abd el-Latif FF. Fenugreek attenuation of diabetic nephropathy in alloxan-diabetic rats: attenuation of diabetic nephropathy in rats. J Physiol Biochem. 2012;68:263–9.PubMedCrossRef

98.

Chang B, Jin C, Zhang W, Kong L, Yang JH, Lian FM, Li QF, Yu B, Liu WK, Yang LL, Zhao P, Zhen Z. Euonymus alatus in the treatment of diabetic nephropathy in rats. Am J Chinese Med. 2012;40:1177–87.CrossRef

99.

Sohn E, Kim J, Kim CS, Kim YS, Jang DS, Kim JS. Extract of the aerial parts of Aster koraiensis reduced development of diabetic nephropathy via anti-apoptosis of podocytes in streptozotocin-induced diabetic rats. Biochem Biophy Res Co. 2010;391:733–8.CrossRef

100.

Lin CC, Lin LT, Yen MH, Cheng JT, Hsing CH, Yeh CH. Renal protective effect of xiao-chai-hu-tang on diabetic nephropathy of type 1-diabetic mice. Evid Based Complement Alternat Med. 2012;2012:984024.PubMedCentralPubMed

101.

He LQ, Cao HX, Shen YJ. Effect and mechanism of Tangshenning Recipe on micro-albuminuria in rats with early diabetic nephropathy. Zhong Xi Yi Jie He Xue Bao. 2003;1:119–21.PubMedCrossRef

102.

Liu W, Wang J, Wang X, Yang Q, Wang D. Effects of shenbao recipe on expressions of CTGF and MMP-9 in diabetic nephropathy rats. Zhongguo Zhong Yao Za Zhi. 2010;35:1874–7.PubMed

103.

Liu IM, Tzeng TF, Liou SS, Chang CJ. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription. J Ethnopharmacol. 2009;124:211–8.PubMedCrossRef

104.

Fang D, Wan X, Deng W, Guan H, Ke W, Xiao H, Li Y. Fufang Xue Shuan Tong capsules inhibit renal oxidative stress markers and indices of nephropathy in diabetic rats. Exp Ther Med. 2012;4:871–6.PubMedCentralPubMed

105.

Li LL, Chen ZQ, Wang YH, Zhang JH, Yin ZW, Li LL, Zhang XY, Wang FL. Relationship between urinary nephrin and urinary albumin changes in diabetic rats and effects of Yiqiyangyinhuayutongluo Recipe. J Tradit Chin Med. 2012;32:278–82.PubMedCrossRef

Title: Chinese medicines in the treatment of experimental diabetic nephropathy
Authors: Jing-Yi Liu
Xiao-Xin Chen
Sydney Chi-Wai Tang
Stephen Cho-Wing Sze
Yi-Bin Feng
Kai-Fai Lee
Kalin Yan-Bo Zhang
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: Chinese Medicine / Issue 1/2016
Electronic ISSN: 1749-8546
DOI: https://doi.org/10.1186/s13020-016-0075-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Chinese medicines in the treatment of experimental diabetic nephropathy

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2016

Discriminating from species of Curcumae Radix (Yujin) by a UHPLC/Q-TOFMS-based metabolomics approach

Induction of apoptosis in human hepatocellular carcinoma cells by extracts of Lannea coromandelica (Houtt.) Merr. and Diospyros castanea (Craib) Fletcher

Evaluation of the accuracy of diagnostic scales for a syndrome in Chinese medicine in the absence of a gold standard

Validation of the qi blood yin yang deficiency questionnaire on chronic fatigue

A novel coumarin, (+)-3′-angeloxyloxy-4′-keto-3′,4′-dihydroseselin, isolated from Bupleurum malconense (Chaihu) inhibited NF-κB activity

Patterns of Chinese medicine use in prescriptions for treating Alzheimer’s disease in Taiwan